Dolby Laboratories (DLB) FY2015 results: revenue $971 million, up 1.1% on the year
Dolby Laboratories, Inc. (DLB) reported revenue of $971 million for fiscal 2015, the year ended 25 September 2015, up 1.1% on the year before. Net income was $181 million, down 12.0%, and diluted earnings per share $1.75. The figures are the company's own, from the 10-K it filed with the SEC on 24 November 2015.
Revenue
$971 million
+1.1% on the year
FY2008FY2015
Operating margin
22.0%
28.5% a year earlier
FY2008FY2015
Net income
$181 million
-12.0% on the year
FY2008FY2015
Diluted EPS
$1.75
-12.1% on the year
FY2008FY2015
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Revenue
971
960
910
+1.1%
Cost of revenue
94.8
70.2
96.7
+35.1%
Gross profit
876
890
813
-1.6%
Gross margin
90.2%
92.7%
89.4%
Research and development
201
183
169
+9.9%
Operating income
213
274
245
-22.1%
Operating margin
22.0%
28.5%
27.0%
Interest expense
0.2
-0.2
0.6
Pre-tax income
246
276
251
-11.0%
Income tax
62.5
67.4
60.3
-7.2%
Effective tax rate
25.4%
24.4%
24.1%
Net income
181
206
189
-12.0%
Net margin
18.7%
21.5%
20.8%
Diluted EPS
$1.75
$1.99
$1.84
-12.1%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Operating cash flow
309
362
277
-14.4%
Capital expenditure
158
75.4
26.7
+109.1%
Free cash flow
152
286
250
-46.9%
Free cash flow margin
15.6%
29.8%
27.5%
Cash from investing
-204
-205
175
Cash from financing
-139
-40.6
-488
Depreciation and amortisation
69.1
53.3
53.2
+29.8%
Share-based compensation
67.1
65.7
64.3
+2.1%
Buybacks
107
56.0
82.2
+91.6%
Dividends paid
41.0
0.0
408
Dividend per share
$0.42
$0.00
$4.00
Diluted shares, weighted
104m
104m
103m
+0.2%
Balance sheet
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Shareholders' equity
1,807
1,710
1,481
+5.7%
Non-controlling interest
8.9
21.6
18.9
-58.7%
Debt
0.0
0.0
0.0
Other liabilities
317
252
238
+25.7%
Total liabilities and equity
2,133
1,984
1,738
+7.5%
Fixed assets
403
290
243
+39.1%
Goodwill
308
278
280
+10.9%
Intangible assets
128
63.7
41.3
+100.2%
Investments
460
528
447
-12.8%
Cash and equivalents
532
568
454
-6.4%
Receivables
102
86.2
97.5
+17.9%
Inventory
13.9
8.5
10.1
+62.5%
Other assets
188
162
165
+15.7%
Total assets
2,133
1,984
1,738
+7.5%
10-K for the year ended 25 September 2015, filed 24 November 2015: the filing.